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Abstract
Glycated hemoglobin A1C (HbA1C) level is used as a diagnostic marker for diabetes mellitus and a predictor of
diabetes associated complications. Genome-wide association studies have identified genetic variants associated with
HbA1C level. Most of these studies have been conducted in populations of European ancestry. Here we report the
findings from a meta-analysis of genome-wide association studies of HbA1C levels in 6,682 non-diabetic subjects of
Chinese, Malay and South Asian ancestries. We also sought to examine the associations between HbA1C associated
SNPs and microvascular complications associated with diabetes mellitus, namely chronic kidney disease and
retinopathy. A cluster of 6 SNPs on chromosome 17 showed an association with HbA1C which achieved genome-wide
significance in the Malays but not in Chinese and Asian Indians. No other variants achieved genome-wide
significance in the individual studies or in the meta-analysis. When we investigated the reproducibility of the findings
that emerged from the European studies, six loci out of fifteen were found to be associated with HbA1C with effect
sizes similar to those reported in the populations of European ancestry and P-value ≤ 0.05. No convincing
associations with chronic kidney disease and retinopathy were identified in this study.
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Introduction
Glycated hemoglobin A1C (HbA1C) is formed through the non-
enzymatic glycation of hemoglobin. In patients with diabetes
mellitus, it is used as a therapeutic target against which
glucose lowering therapies can be titrated, as it shows a good
correlation with the risk of developing microvascular
complications associated with diabetes mellitus. It also shows
less intra-individual variability than both fasting glucose and 2
hour post challenge glucose after an oral glucose tolerance test
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and can be measured without the need for fasting. For these
reasons, it has been recommended as a criterion to diagnose
diabetes [1,2].
HbA1C levels show significant heritability, with twin studies
conducted in Europeans estimating a heritability of 75% [3].
Several genome-wide association studies (GWAS) have been
conducted in populations of European ancestry: a GWAS
conducted in 14,618 women identified 4 loci harboring variants
associated with HbA1C [4]; a study of 1,782 Europeans found
suggestive evidence for an association with HbA1C at the
TCF7L2 locus [5]; and a meta-analysis of 31 genome-wide
studies across 68,000 European samples revealed 10 loci
harboring variants associated with HbA1C [6]. However, several
questions remain unanswered.
Firstly, are there novel variants that can be found through
GWAS in populations of non-European ancestry, either
because the variants are more common in those populations,
or there are ethnic specific effects observed? Secondly, are the
findings from studies conducted in European populations
transferable to Asian populations? A study in the United States
showed differences in both allele frequency and the magnitude
of the association for HbA1C associated SNPs between race/
ethnic groups [7]. However, few studies have been conducted
in Asians with the exception of one study conducted in over
8,000 Koreans which identified variants at the CDKAL1 locus
which were associated with type 2 diabetes (T2D) and HbA1C
[8].
Thirdly, it is also unclear if these variants are associated with
the complications associated with T2D. One study conducted in
the North America showed that HbA1C associated SNPs were
not associated with mortality [7] and coronary artery disease
[6]. However, to our knowledge, the association between HbA1C
associated SNPs and microvascular complications (which
show a much stronger association with blood glucose than
either mortality or cardiovascular disease) has not been
examined. The relationship between glycemia and
microvascular complications in patients without T2D may be
particularly relevant given that we have shown that the
relationships between blood glucose and both macro- and
micro-vascular disease are monotonic, and extend down into
the normal blood glucose range [9-11].
Here we describe the findings of three genome-wide surveys
of HbA1C that were conducted in 6,682 individuals from three
populations of Asian ancestry, which include 3,427 Chinese,
1,735 Malays and 1,520 Asian Indians residing in Singapore.
We aimed to answer the three questions mentioned above.
Materials and Methods
Ethics statement
The sample recruitment was approved by The Singapore
General Hospital Ethics Committee and the Singapore Eye
Research Institute Ethics Committee. The genetic analysis was
approved by the National University of Singapore Institutional
Review Board (Approval Certificate NUS465). All participants
provided written informed consents.
Study cohorts
A flow chart which described the process from sample
recruitment to association analysis was presented in Figure S1.
The Singapore Prospective Study Program (SP2) first
surveyed the subjects between the ages of 24 and 95 years
from four previous cross-sectional studies: Thyroid and Heart
Study (1982–1984), National Health Survey (1992), National
University of Singapore Heart Study (1993–1995) and the
National Health Survey (1998). Each of these studies randomly
sampled individuals from the Singapore population, although a
disproportionate sampling scheme was utilized to increase the
sample sizes of the minority ethnic groups (Malays and Asian
Indians). Between 2003 and 2007, we revisited these subjects.
Of the 10,747 subjects who were eligible, we successfully
recruited 6,968 subjects who completed a questionnaire. 5,157
subjects in this cohort also completed the subsequent clinical
examination which included venesection for the collection of,
among other things, DNA for genetic analysis. The Singapore
Malay Eye Study (SiMES) is a population-based, cross-
sectional epidemiological study of 3,280 Malay adults living in
15 residential districts in the southwestern part of Singapore
[12]. The Singapore Indian Eye Study (SINDI) and the
Singapore Chinese Eye Study (SCES) are respectively the
Asian Indian and Chinese equivalent to SiMES, where the
sampling was similarly performed in the same 15 residential
districts and included 3,400 Asian Indians and 3,353 Chinese
respectively.
Genotyping and data quality control
Of the 5,157 SP2 individuals who finished the questionnaire
and clinical examination, 3,236 individuals of Chinese ancestry
had their blood samples collected. We genotyped 2,857 of
these individuals on three different Illumina arrays (San Diego,
California, the United States), with 583 samples on the
HumanHap550v3, 1,467 samples on the HumanHap 610Quad
and 1,016 samples on the HumanHap 1Mduov3. The coverage
of these SNP arrays in HapMap JPT+CHB panel were
comparable to that in populatoins of European ancestry
[13,14]. Samples from the remaining three cohorts, 1,952 from
SCES, 3,072 from SiMES and 2,953 from SINDI, were
successfully genotyped on the HumanHap 610Quad array. For
each cohort, a preliminary SNP quality control (QC) was
conducted to remove SNPs that: (i) are monomorphic; (ii) are
of high rates of missingness (> 5%); or (iii) exhibit evidence of
departure from Hardy-Weinberg Equlibrium (HWE P < 10-6); (iv)
cannot be mapped to the forward strand of the human genome
build 36. Using the remaining SNPs, samples are removed on
the basis of missingness, excessive heterozygosity,
relatedness, discordant ethnic membership or discrepancy
between the genetically inferred and clinically recorded
genders. With the post-QC samples, we re-analyzed the SNP
quality metrics. We excluded a SNP if it: (i) could not be
mapped to the forward strand of the human genome build 36;
(ii) displayed excessive missingness (>5%); (iii) exhibited
evidence of departure from Hardy-Weinberg Equlibrium (HWE
P ≤ 10-6); (iv) was monomorphic; or (v) was non-autosomal.
The numbers of samples removed in each step and remained
after QC of our studies were presented in Figure S1.
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Imputation
To maximize the information available, we imputed the
genotypes for all samples using the phased haplotypes in
Phase 2 release 22 of the International HapMap Project
(HapMap2 r22) using either IMPUTE v0.5.0 [15] (SP2, SiMES
and SINDI) or IMPUTE v2.1.2 (SCES) [16]. The two IMPUTE
versions implemented different algorithms, but the imputation
accuracy does not differ significantly [16]. The Chinese
samples in SP2 and SCES were imputed using reference
panels derived from HapMap Han Chinese from Beijing (CHB)
and the Japanese in Tokyo (JPT) resulting about 2.4 million
imputed SNPs. The Malay and Indian samples were imputed
against a combined reference panel of Caucasians (CEU),
East Asians (JPT+CHB) and Africans (YRI) resulting in about
1.9 million imputed SNPs. Each chromosome was divided into
5Mb regions for imputation with a 250kb buffer added to each
flank. We retained only the imputed SNPs with information
criterion ≥ 0.5.
Phenotype definition
HbA1C was measured by high pressure liquid
chromatography using a method that was certified by the
National Glyoprotein Standardization program with controls
traceable to the diabetes control and complications trial [10,11].
Creatinine was measured by enzymatic methods
implemented on the ADVIA 2400 (Bayer Diagnostics,
Tarrytown, New York, United States of America) [17].
Glomerular filtration rate (GFR) was estimated using the
Modification of Diet in Renal Disease (MDRD) [18]. Chronic
kidney disease (CKD) was defined as estimated glomerular
filtration rate (eGFR) less than 60 and greater than or equal to
0, while control’s eGFR is greater than or equal to 60 [11].
Diabetic retinopathy (DR) was evaluated following a standard
protocol based on retinal photographs which were graded
according to a modified scale from Airlie House classification
system [19]. Two definitions for DR were employed, (i)
moderate/severe DR was defined as grade ≥ 30 (ii) any DR
was defined as grade ≥ 14. In both instances, controls had
grade < 14 [20-22].
Associations with HbA1C
To identify SNPs associated with HbA1C, we excluded all
subjects with diabetes which was defined as anyone who a)
gave a self-reported a diagnosis of diabetes given by a
physician, b) was taking medications for diabetes, or c) had
HbA1C ≥ 6.5%. In addition, in SP2, we also excluded individuals
with fasting glucose ≥ 7mmol/L [2]. More detail on the number
of excluded samples can be found in Figure S1.
The three ethnic groups in Singapore exhibit significant
genetic differences [23] and phenotypic differences [24,25]. In
order to avoid any population stratification that might occur due
to these differences, association testing was first performed
within each ethnic group. For each cohort, the HbA1C
percentage was regressed against the allele dosage of the
SNP assuming a linear model adjusted for age and gender
using SNPTEST v2.2 [15]. We further controlled for population
stratification by adjusting for principal components (PCs). The
principal component analyses was calculated using an
independent set of SNPs (r2<0.2) across the autosomal
chromosomes by EIGENSTRAT [26]. The distribution of the
PCs was observed in each cohort. For SiMES, the first two
principal components from the PCA were additionally included
as covariates to control for population stratification, while three
principal components were included for SINDI. No principal
component was adjusted for in the Chinese studies because
there is no significant stratification shown in the cohorts (Figure
S2, S3, S4). We further removed the genotyped and imputed
SNPs of minor allele frequency (MAF) < 1%, missing rate > 5%
or HWE P value ≤ 10-6. Finally, we applied genomic control to
each study before meta-analysis to control for the remaining
minor inflation in the test statistics. The inflation factor (λGC)
calculated using the genomic control approach was used to
estimate the extent to which the P-values are skewed by the
inflation factors [27]. We used the fixed-effect inverse variance
model in METAL to perform the meta-analyses [28]. The four
Chinese GWAS (SP2-550, SP2-610, SP2-1M, SCES) were first
meta-analyzed together to yield a single study for the Chinese
ethnic group. Subsequently, a meta-analysis was performed to
integrate the results from the combined Chinese study, SiMES
and SINDI.
Selection of European established index SNPs
associated with HbA1C
We searched the literature to identify SNPs associated with
HbA1C which had shown strong evidence of association with
HbA1C in populations of European ancestry. We identified 11
SNPs from Soranzo et. al. [6], 4 SNPs from Pare et. al.[4], 1
SNP from Franklin et. al. [5] and investigated the transferability
of these 16 associations to the Asian populations that are the
subject of this study.
Calculation of regional FST and haplotype entropy
The fixation index (FST) is a common measure of
differentiation and genetic distance. It has been shown that the
FST scores for SNPs in a region are indicative of the
reproducibility of association signals across populations [29].
We thus calculated the regional FST surrounding an index SNP,
defined as the average of SNP-level FST for SNPs that are
shared across the populations and are located within 50 Kb of
either flanks of the index SNP. It has also been shown that
evaluating the entropy of haplotype frequencies can be
predictive of meta-analysis efficiency, which is a surrogate for
the transferability of genetic association signals across
populations [29,30]. For each index SNP, we also considered
the 100 Kb region flanking the index SNP across the
populations, and identified the set of unique haplotypes that are
present in at least 2% of each population. These haplotypes
were collated across every pair of populations consisting of
CEU and one of the three Singapore populations, and the
frequency of each of the ith haplotype in the jth population was
calculated and defined as fij. The posterior probability of each
population conditional on the ith haplotype, Fij, is fij/(Σjfij), and the
relative mutual information for the ith haplotype can be
calculated as RMI(i) = 1 + Σj(Fij log Fij)/log(2). We thus defined
the haplotype entropy for the genomic region as the overall-
frequency weighted sum of the individual relative mutual
Association and Pleotropic Effect of HbA1C Loci
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information estimates, or Σi[(Σifi•) RMI(i)]/ (Σifi•), where fi•
represent the frequency of the ith haplotype in the two
populations. The haplotype entropy metric effectively quantifies
the degree of population-specificity of each haplotype, and is
bounded between 0 and 1. Larger values mean there are
particular haplotypes that are more common in some
populations than others, and thus indicate that there is greater
haplotype diversity between the populations queried. The
significance of the difference in regional FST and haplotype
entropy between failed and replicated associations was
evaluated by one-tail t-tests assuming equal variance.
Associations with CKD and DR
These associations were assessed separately in those with
and without T2D. For these analyses, T2D cases were defined
as HbA1C ≥ 6.5%, or self-reported diabetic history. T2D controls
were defined as HbA1C < 6% and no diabetes history.
Especially for SP2 samples, T2D controls were defined as
fasting glucose ≤ 6 mmol/L and no diabetic history. We did not
conduct the association tests of CKD and DR in the SP2
individuals with diabetes due to the very limited number of both
CKD cases and DR cases in this cohort (data not shown).
Association tests were done using logistic regression
implemented with SNPTEST v2.2 without considering any
covariates except PC1 and PC2 for SiMES and PC1 to PC3 for
SINDI. We tested the association of the 16 European
established SNPs with DR and CKD in our cohorts. The
association was stratified into T2D cases and T2D controls,
and the association results were meta-analyzed within cases,
controls and all samples separately using the fixed effect
inverse variance scheme as implemented in METAL.
Results
Genome-wide association study and meta-analysis of
HbA1C
The characteristics of the samples from the investigated
studies are summarized in Table 1. The inflation factors for all
3 populations were all close to 1, suggesting that significant
population stratification was not present or properly controlled
in our study. Moreover, the meta-analysis inflation factor was
0.999.
The separate genome-wide scans for Chinese, and Indians
did not reveal any genome-wide significant associations
(Figure S5A and 5C). In the Malays, six SNPs at one locus
near the G6PC3 gene on chromosome 17 exhibited evidence
in excess of genome-wide significance (leading SNP:
rs12603404, P = 3.89x10-22, Figure S5B). However, this
association was not replicated in the Chinese or the Indians
(Table S1) despite similar allele frequencies for these SNPs in
all 3 populations. The meta-analysis of all three studies across
a total of 6,682 samples did not reveal any additional SNPs at
genome-wide significance (Figure 1). The quantile-quantile
plots (Q-Q plots) adjusted for the corresponding inflation
factors did not show significant inflation, nor did they show
obvious departure from the null hypothesis of no association
between genes and HbA1C in our cohorts, except for the
Malays (Figure S6).
Transferability of European findings in Asian
populations.  We next sought to determine whether the
previous findings established in populations of European
ancestry are relevant and transferable to populations of non-
European ancestry. Of the 16 SNPs that show an association
with HbA1C in populations of European Ancestry, 14 were
present and polymorphic in our studies across all three ethnic
groups. For the remaining two index SNPs, rs16926246 at the
HK1 locus is present only in the Indian GWAS because of the
poor imputation quality in Chinese and Malays and rs1800562
at the HFE locus had a MAF of 0.2% in Indians and is
Table 1. Demographics of the investigated studies.
Study SP2-1M SP2-610 SP2-550 SCES Chinese combine SiMES SINDI
N 779 797 266 1585 3427 1735 1520
Men (%) 61.54 16.99 66.03 50.38 46.35 49.74 49.14
age 46.74(10.13) 47.42(10.61) 48.27(12.24) 57.69(9.40) 52.08(11.37) 57.59(11.21) 56.42(9.76)
BMI 22.75(3.39) 22.20(3.71) 23.28(3.47) 23.46(3.46) 22.99(3.54) 25.73(5.09) 25.66(4.52)
HbA1c (%) 5.6(0.4) 5.63(0.4) 5.60(0.4) 5.81(0.3) 5.71(0.4) 5.71(0.4) 5.68(0.4)
HbA1c (mmol/mol) 38(4.4) 38(4.4) 38(4.4) 40(3.3) 39(4.4) 39(4.4) 39(4.4)
Inflation Factor 1.01 1.02 0.994 0.997 1.005 1.003 0.998
N, sample size; Men (%) is the percentage of males in each cohort.
The inflation factors were obtained after adjusting for age, sex, BMI and PCs (for SiMES and SINDI only).
Age, BMI and HbA1C are given as mean(SD). HbA1C is given in both DCCT-derived (%) and IFCC-recommended (mmol/mol) units.
SP2, Singapore Prospective Study Program. SP2-1M, SP2-610 and SP2-550 are the SP2 samples genotyped on Ilumina HumanHap 1M Duo, 610 Quad and 550 v3 SNP
arrays respectively.
SCES, Singapore Chinese Eye Study. The combined Chinese included the three SP2 cohorts and SCES. SiMES, Singapore Malay Eye Study.
SINDI, Singapore Indian Eye Study.
doi: 10.1371/journal.pone.0079767.t001
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monomorphic in both Chinese and Malays, and thus did not
pass our quality control filter. As a result, we have 14 SNPs in
Chinese and Malays, 15 SNPs in Indian and 14 SNPs in meta-
analysis respectively for our transferability investigation.
Six, four, three and seven of the SNPs under investigation
were associated with HbA1C variation in the Chinese, Malays,
Asian Indians and the combined meta-analysis respectively at
a P-value ≤ 0.05 (Table 2). To determine the reasons for the
failure of other SNPs to show even nominal association with
HbA1C, we next estimated the powers of our study to detect
these associations based on the sample sizes available to us,
the allele frequency of the variants in our populations and the
effect estimates derived from the respective populations (Table
S2). We have higher powers at the SNPs with P-value ≤ 0.05
(range from 17.1% to 93.8% in the individual ethnic groups)
than the SNPs with P-value > 0.05 (range from 5.0% to 36.7%
in the individual ethnic groups). Given that our study was
underpowered to detect many of these associations, we also
compared the effect sizes for each of these SNPs in our study
and those observed in populations of European ancestry
(Figure 2). For most of the variants, including those that failed
to replicate in our studies, the directions of the effects in our
study were consistent with those seen in the populations of
European ancestry. In the meta-analysis across all three ethnic
groups, there was only one SNP, rs7903146 in TCF7L2, which
displayed an opposite direction of effect compared to that
observed in populations of European ancestry. However, it
should be noted that the allele frequency and sample size
resulted in very limited power (6.2% in the meta-analysis) to
detect the association at this locus in our study.
Given the varying success in the Asian studies at
reproducing the reported associations, we also investigated
whether population differences in the genetic architecture could
have contributed to this failure to replicate the associations. We
calculated the regional FST and haplotype entropy between the
HapMap Europeans (CEU) and each of the three Asian
populations in the Singapore Genome Variation Project
(SGVP) [23] for a 100 Kb region flanking each of the 16 index
SNPs (Table S2). SGVP consists of three panels, Singapore
Chinese (CHS), Malays (MAS) and Indians (INS). We only
considered the pairs of CEU and SGVP populations as we are
interested to evaluate the replicability of findings that were
originally discovered in populations of European ancestry. We
observed that, across our genome-wide surveys, the regional
FST for the loci that replicated were significantly lower than
those that failed to replicate (two-sample t-test P-value =
3.12x10-5), indicating that genetic diversity between European
and the Asian populations is likely to contribute to our inability
Figure 1.  Manhattan plot and Q-Q plot of genome-wide meta-analysis.  (A) The Manhattan plot of the meta-analysis of
Chinese, Malays and Indians. The minus log10 of P-values (Y-axis) of inverse-variance meta-analysis across the 22 autosomal
chromosomes after genomic control were plotted against the genomic coordinates. The horizontal line represents the genome-wide
significant level of 5x10-8. (B) Q-Q plot of the observed P-values (Y-axis) against the expected P-values (X-axis). The diagonal line
and its 95% confidence envelop were also plotted.
doi: 10.1371/journal.pone.0079767.g001
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to reproduce the associations at the index SNPs. The
haplotype entropy values were also lower for the loci that
successfully replicated than those that did not replicate but this
difference did not reach statistical significance (P-value = 0.08).
Associations with diabetic retinopathy and chronic
kidney disease
The case-control studies of CKD and DR were done in over
1800 subjects with T2D and 4400 without T2D. The prevalence
of both CKD and DR are much higher in T2D cases than in
T2D controls (Table 3). No SNP was associated with CKD in
subjects without T2D. Of the 15 HbA1C index SNPs, one SNP,
rs2779116 at the SPTA1 locus, was significantly associated
with CKD in subjects with T2D (P value = 1.7 x 10-3, OR =
1.31). The significance was diminished after combining with the
results from those without T2D (Table 4). Two other SNPs
(near the ANK1 and HK1 loci) also showed nominal
significance in the meta-analysis combining those with and
without T2D. However, neither of them reached the Bonferroni
corrected significance level of 8.3 x 10-4 (0.05 divided by 15
SNPs and 4 phenotypes). We observed only one SNP,
rs16926246 at the HK1 locus, which showed nominal
significant association with moderate/severe diabetic
retinopathy (P value = 3.88 x 10-2, OR = 0.54) when all subjects
with and without T2D were combined (Table S3). Moreover, for
any retinopathy, there were several nominally significant
associations with SNPs close to the ANK1, SLC30A8,
MTNR1B, TMPRSS6 and HK1 loci. However, none remained
after Bonferroni correction (Table S4). Most of these were
observed in subjects without T2D.
Discussion
We have performed a genome-wide survey of HbA1C variants
in 6,682 Chinese, Malays and Asian Indians in Singapore. To
the best of our knowledge, this is the first time a GWAS for
HbA1C has been reported for Malays and Indians. While a locus
on chromosome 7 near the G6PC3 locus reached genome-
wide significance in Malays, this finding was not replicated in
Chinese or Indians. The meta-analysis of these three ethnic
Figure 2.  Bivariate plots of the effect sizes in Asian cohorts and European ancestry cohorts.  The effect sizes reported in the
European ancestry were plotted against the ones discovered in our studies. The Y-axis corresponds to the European effect size,
while the X-axis corresponds to the effect in Chinese (A), Indians (B), Malays (C) and Meta-analysis (D). The SNPs which are
replicated in our studies at the P-value of 0.05 level were designated by red dots, while the SNPs failed to be replicated were
designated by black dots. The SNPs with inconsistent effect directions between European and each population were labeled by the
reported gene names.
doi: 10.1371/journal.pone.0079767.g002
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groups also did not identify any associations that achieved
genome-wide significance.
Our study confirms that genetic loci that have been
previously established to be associated with HbA1C in
populations of European ancestry show similar direction and
magnitude of effect in these Asian populations. Only a few of
Table 3. Sample size and prevalence rate of stratified
cohorts in CKD and DR analysis.
 CKD Moderate/ severe DR Any DR
T2D cases 2072, 22.1% 1802, 21.0% 2022, 29.6%
SCES 302(42/260) 267(46/221) 296(75/221)
SiMES 794(279/515) 677(130/547) 761(214/547)
SINDI 976(136/840) 858(203/655) 965(310/655)
T2D controls 5201, 6.9% 4409, 0.4% 4619, 4.9%
SCES 1090(51/1039) 1035(2/1033) 1082(49/1033)
SP2-1M 891(30/861) 609(5/604) 641(37/604)
SP2-610 811(20/791) 529(3/526) 549(23/526)
SiMES 1240(205/1035) 1130(3/1127) 1195(68/1127)
SINDI 1169(52/1117) 1106(5/1101) 1152(51/1101)
Total 7273 6211 6641
Sample sizes of separate cohorts are represented by # total (# cases / # controls)
For the stratified totals, "T2D cases" and "T2D controls", the number of samples
and prevalence rate of CKD and DR are present.
The CKD case was defined as 0 ≤ eGFR < 60. The CKD control was defined as
eGFR ≥ 60;
Retinopathy was graded according to the modified Airlie House classification
system. The moderate/severe DR case was defined as grade ≥ 30, while any DR
was defined as grade ≥ 14. In both definitions, controls were those of grade < 14.
doi: 10.1371/journal.pone.0079767.t003
these associations were statistically significant, which likely
relates to relatively low power in our study. For example, the
frequency of the effect allele at the European index SNP
(rs7903146) at TCF7L2 is 28%, as compared to 2% and 4% in
the Chinese and Malays respectively. Notably, this index SNP
showed opposite effect directions across the three Asian
studies. In addition, TCF7L2 has been reported to be
differentially selected between Asian and European
populations [31].
Owing to the reliance of GWAS on tagging markers that, by
themselves, are not functional, we also considered the
possibility that differences in genetic architecture (measured
using the FST score and haplotype entropy) at these
established loci could contribute to the lack of transferability of
the findings related to the index SNP between populations.
Higher regional FST and haplotype entropy between Europeans
and Chinese/Malays at loci such as TCF7L2, HK1 and G6PC2/
ABCB11 suggest that the power to reproduce the European
findings for these index SNPs would be even lower in our study
populations than the allele frequency and sample size might
suggest.
A study conducted in over 8,000 Korean healthy individuals
identified a SNP at the CDKAL1 locus that has been
consistently reported for T2D association across populations of
varying ancestries [32-37] was also associated with HbA1C [8].
However, the index SNP in this Korean study (rs7747752) did
not show a statistically significant association with HbA1C in our
cohorts (P-value = 0.79 in Chinese, 0.92 in Malays, 0.19 in
Indians, and 0.47 in meta-analysis). Nonetheless, this SNP
shows an association with T2D in our populations that is similar
to that observed in others [38] and the lack of association if our
study is possibly due to the insufficient power (5.5% in
Table 4. Association evidence of European established HbA1C SNPs with CKD.
       Combined  T2D Cases  T2D Controls
SNP Chr BP Gene EA OA EAF OR[0.95CI] P-value  OR[0.95CI] P-value  OR[0.95CI] P-value
rs2779116 1 156,852,039 SPTA1 T C 0.42 1.16 [1.03, 1.31] 1.24E-02  1.31 [1.11, 1.56] 1.70E-03  1.04 [0.88, 1.22] 6.48E-01
rs1402837 2 169,465,600 G6PC2 T C 0.36 1.04 [0.92, 1.16] 5.40E-01  1.02 [0.86, 1.20] 8.35E-01  1.06 [0.90, 1.24] 5.11E-01
rs552976 2 169,499,684 G6PC2,ABCB11 A G 0.10 0.96 [0.77, 1.20] 7.29E-01  0.81 [0.61, 1.07] 1.42E-01  1.29 [0.89, 1.87] 1.78E-01
rs730497 7 44,190,246 GCK A G 0.15 0.94 [0.80, 1.10] 4.48E-01  0.96 [0.77, 1.21] 7.48E-01  0.91 [0.73, 1.15] 4.49E-01
rs1799884 7 44,195,593 GCK T C 0.14 0.94 [0.80, 1.11] 4.71E-01  0.97 [0.77, 1.22] 7.91E-01  0.91 [0.72, 1.15] 4.47E-01
rs6474359 8 41,668,351 ANK1 T C 0.97 1.60 [1.07, 2.38] 2.19E-02  1.53 [0.84, 2.80] 1.69E-01  1.65 [0.97, 2.82] 6.52E-02
rs4737009 8 41,749,562 ANK1 A G 0.41 0.90 [0.78, 1.04] 1.44E-01  0.84 [0.68, 1.03] 8.58E-02  0.96 [0.79, 1.17] 7.01E-01
rs13266634 8 118,253,964 SLC30A8 T C 0.42 1.03 [0.92, 1.15] 6.57E-01  1.04 [0.88, 1.22] 6.68E-01  1.02 [0.87, 1.19] 8.40E-01
rs7072268 10 70,769,919 HK1 T C 0.67 1.17 [1.03, 1.31] 1.15E-02  1.18 [1.00, 1.39] 5.17E-02  1.15 [0.97, 1.37] 1.04E-01
rs7903146 10 114,748,339 TCF7L2 T C 0.16 1.02 [0.85, 1.24] 7.99E-01  1.05 [0.84, 1.33] 6.59E-01  0.97 [0.70, 1.34] 8.59E-01
rs1387153 11 92,313,476 MTNR1B T C 0.43 0.93 [0.83, 1.04] 2.05E-01  0.92 [0.79, 1.07] 2.61E-01  0.95 [0.81, 1.11] 5.10E-01
rs7998202 13 112,379,869 ATP11A,TUBGCP3 A G 0.92 0.97 [0.79, 1.18] 7.64E-01  0.87 [0.67, 1.13] 2.94E-01  1.12 [0.83, 1.52] 4.56E-01
rs1046896 17 78,278,822 FN 3K T C 0.45 1.05 [0.94, 1.17] 4.00E-01  1.07 [0.92, 1.25] 3.76E-01  1.02 [0.87, 1.20] 7.70E-01
rs855791 22 35,792,882 TMPRSS6 A G 0.55 0.93 [0.83, 1.04] 1.88E-01  0.92 [0.79, 1.06] 2.51E-01  0.94 [0.81, 1.11] 4.78E-01
rs16926246 10 70,763,398 HK1 T C 0.05 0.84 [0.47, 1.50] 5.53E-01  0.54 [0.27, 1.09] 8.53E-02  2.37 [0.81, 6.97] 1.17E-01
The association of CKD was done in T2D cases and controls separately. The results were then combined using fixed effect meta-analysis. Chr, represents the chromosome
number of the SNPs; BP, base pair position; EA, effect allele; N, sample size; EAF, effect allele frequency. OR and 0.95 confident interval were calculated from the logistic
regression coefficient and its standard error. Significant P-values less than or equal to 0.05 are highlighted in bold.
doi: 10.1371/journal.pone.0079767.t004
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Chinese, 5.1% in Malays, 25.1% in Indians and 10.2% in meta-
analysis).
In thinking about the associations between HbA1C associated
SNPs and DR/CKD, we need to consider the mechanisms that
explain the association between these variants and HbA1C. The
proportion of HbA1C is highly correlated with the average
glucose level in the blood over a period of time [39]. It would
not, therefore, be surprising that several of the genetic loci
identified in association with HbA1C could show an association
with microvascular complications that is mediated by blood
glucose. Our study showed nominal associations between
variants at the SLC30A8 and MTNR1B loci with any diabetic
retinopathy (Table S4). Since this phenotype is known to be
associated with blood glucose [9-11], and both these loci are
known to be associated with T2D and blood glucose, these
findings are not surprising. On the other hand, several loci also
showed associations with various erythrocyte parameters
(SPTA1, HFE, ANK1, HK1, TMPRSS6). Furthermore, rare
variants at these loci are known to cause hereditary anemia,
suggesting that these variants primarily alter erythrocyte
physiology. While these variants may affect the utility of HbA1C
in diabetes diagnosis, they are less likely to be associated with
microvascular complications. Yet, we did observe an
association between the index SNP at the SPTA1 and CKD. In
addition, variants at the HK1 locus were associated with CKD,
moderate/severe DR and any DR. An index SNP at the ANK1
locus also associated with CKD and retinopathy in non-diabetic
individuals. This raises the possibility that the pathogenesis of
diabetic complications is more complex than that of blood
glucose alone, and we should not ignore variants just because
they are associated with erythrocyte parameters. However, it
should be noted that most of these associations, apart from
SPTA1 with CKD, did not survive correction for multiple testing
and the significance of these findings is uncertain.
Finally, there are some variants that do not show association
with either blood glucose or erythrocyte parameters. These
include FN 3K, which deglycates hemoglobin and other
glycated proteins formed under hyperglycemic conditions.
These variants could potentially affect not only HbA1C, but also
the downstream products of non-enzymatic protein glycation,
the advanced glycation end-products, which may have an
important role in the pathogenesis of microvascular
complications associated with T2D [40]. In fact, a small study
suggested that variants at this locus are associated with the
progression of diabetic nephropathy [41]. Our data does not
support this previous finding.
In conclusion, we identified a low frequency variant near the
G6PC3 locus in Malays living in Singapore, which was not
replicated in Chinese and South Asians. This finding requires
confirmation in future studies. We also showed that most SNPs
associated with HbA1C in populations of European ancestry are
also relevant to Asian populations. Furthermore, among the 15
HbA1C index SNPs, we identified one significant association
between SPTA1 and CKD.
Supporting Information
Figure S1.  Flow chart of the GWAS meta-analysis. SP2,
Singapore Prospective Study Program; SCES, Singapore
Chinese Eye Study; SiMES, Singapore Malay Eye Study;
SINDI, Singapore Indian Eye Study; Illu610, Illu1M and Illu550
are Illumina HumanHap 610 Quad, 1M Duo and 550 v3 array
platforms respectively.
(JPG)
Figure S2.  Principle component analysis of SP2 and SCES
study. (A) the first (PC1) and the second principle component
(PC2) of Chinese samples with Singapore Genome Variation
Project (SGVP) individuals. These Chinese samples included
the tested individuals of the three Singapore Prospective Study
Program cohorts and Singapore Chinese Eye Study.
(B) the first (PC1) and second principle component (PC2) of
Chinese samples in our study.
(JPG)
Figure S3.  Principle component analysis of SiMES study.
(A) the first (PC1) and the second principle component (PC2)
of Malay samples with Singapore Genome Variation Project
(SGVP) individuals.
(B) the first (PC1) and second principle component (PC2) of
Malay samples in our study.
(JPG)
Figure S4.  Principle component analysis of SINDI study.
(A) the first (PC1) and second principle component (PC2) of
Indian samples with Singapore Genome Variation Project
(SGVP) individuals.
(B) the first (PC1) and second principle component (PC2) of
Indian samples in our study.
(C) the second (PC2) and third principle component (PC3) of
Indian samples with SGVP individuals.
(D) the second (PC2) and third principle component (PC3) of
Indian samples in our study.
(JPG)
Figure S5.  Genome-wide association scans in Chinese,
Malays and Indians separately. The –log10 of P-values (Y-
axis) of combined Chinese (A), Malays (B) and Indians (C) are
plotted against the genomic coordinates (X-axis). Only
autosomal chromosomes are plotted.
(JPG)
Figure S6.  Q-Q plots of genome-wide association P-values
of Chinese, Malays and Indians separately. A, B and C are
the Q-Q plots of combined Chinese, Malays and Indians
respectively. The Y-axis represents the observed distribution of
P-values while the X-axis represents the expected distribution.
(JPG)
Table S1.  G6PC3 significant SNPs in Malays, Chinese,
Indians and meta-analysis. Chr, represents the chromosome
number of the SNPs; BP, position; EA, effect allele; OA, other
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allele; N, sample size; EAF, effect allele frequency; Beta, linear
regression coefficient; SE, standard error of Beta; Cohort, the
population in which the statistic was measured. Among the
cluster of SNPs, rs12603404 was genotyped in all cohorts,
hence chosen as index SNP. Note that rs5036 was poorly
imputed in SINDI (r2=0.12), so its result in Indians is not
shown.
(DOCX)
Table S2.  Transferability of European established loci in
Asian populations. Chr, represents the chromosome number
of the SNPs; Pos, position; EA, effect allele; OA, other allele;
N, sample size; EAF, effect allele frequency; Beta, linear
regression coefficient; SE, standard error of Beta; R_Fst,
regional FST; hap_ent, haplotype entropy. The literatures from
which we extracted the reported effect are given in the source
column. Whenever possible, we adopted the reported effect
from Soranzo, et.al. Regional FST and haplotype entropy were
only calculated for each population, instead of the meta-
analysis.
(DOCX)
Table S3.  Association evidence of European established
HbA1C SNPs with moderate/severe DR. Retinopathy was
graded according to the modified Airlie House classification
system. The moderate/severe diabetes retinopathy (DR) was
defined as case: grade >=30; control: grade < 14. The odds
ratios (OR) and 95% confidence interval (CI) were calculated
from the beta coefficients of the logistic regression. P-values
less than or equal to 0.05 are highlighted in bold.
(DOCX)
Table S4.  Association evidence of European established
HbA1C SNPs with any DR. Retinopathy was graded according
to the modified Airlie House classification system. Any DR case
was defined as grade >=14, while control was defined as grade
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